RASSEGNA DEI LAVORI SCIENTIFICI DI Franco Brunello, Eugenio Caturelli e Antonio Giorgio

11/10/2014

1. Eugenio Caturelli, Giannini E.G., et alii (Italian Liver Cancer [ITA.LI.CA] group):Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma Identified During Surveillance in Compensated Cirrhosis.  Hepatology. 2012 Oct;56(4):1371-9. doi: 10.1002/hep.25814. SCARICA IL FILE

2.Eugenio Caturelli, Giannini E.G., et alii (Italian Liver Cancer [ITA.LI.CA] group):  Ten-Year Outcome of Radiofrequency Thermal Ablation for Hepatocellular Carcinoma: An Italian ExperienceLetter to editor.Am J Gastroenterol. 2012 Oct;107(10):1588-9; author reply 1590. doi: 10.1038/ajg.2012.250.

3. Eugenio Caturelli, Giannini E.G., et alii (Italian Liver Cancer [ITA.LI.CA] group): Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma Cancer. 2014 Jul 15;120(14):2150-7. doi: 10.1002/cncr.28706. Epub 2014 Apr 10. ABSTRACT

 

4. Eugenio Caturelli, Giannini E.G., et alii. Hepatocellular carcinoma in patients without cirrhosis in Italy. Digestive and Liver Disease Volume 45, Issue 2, February 2013, Pages 164–169 ABSTRACT

5. Eugenio Caturelli, Cucchetti A., et alii (Italian Liver Cancer [ITA.LI.CA] group):Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. Journal of Hepatology Volume 61, Issue 2, Pages 333–341, August 2014 ABSTRACT

6. Eugenio Caturelli, Farinata C., et alii (Italian Liver Cancer [ITA.LI.CA] group): Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy. Eur J Gastroenterol Hepatol. 2012 Feb;24(2):195-202. doi: 10.1097/MEG.0b013e32834e153Abstract

7. Eugenio Caturelli, Carr I.B, et alii (Italian Liver Cancer [ITA.LI.CA] group): Significance of platelet and AFP levels and liver function parameters for HCC size and survival.Int J Biol Markers 2014; 29(3): 215 - 223 DOI:10.5301/jbm.5000064 ABSTRACT

8. Eugenio Caturelli, Cazzagon N, et alii (Italian Liver Cancer [ITA.LI.CA] group): Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. Liver International Volume 33, Issue 9, pages 1420–1427, October 2013 ABSTRACT

9. Eugenio Caturelli, Cucchetti A., et alii (Italian Liver Cancer [ITA.LI.CA] group): Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. Journal of Hepatology Volume 56, Issue 5, Pages 1089–1096, May 2012 ABSTRACT

10.Eugenio Caturelli, Del Poggio P., et alii (Italian Liver Cancer [ITA.LI.CA] group): Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. February 26, 2014 DOI: http://dx.doi.org/10.1016/j.cgh.2014.02.025

1/03/2014

1: Franco Brunello, Pompili M, et alii.Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol. 2013 Jul;59(1):89-97. doi: 10.1016/j.jhep.2013.03.009.Epub 2013 Mar 22. PubMed PMID: 23523578.

2: Franco Brunello, Cantamessa A, Rizzetto M et alii. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm. Eur J Gastroenterol Hepatol. 2013 Jul;25(7):842-9. doi: 10.1097/MEG.0b013e32835ee5f1. PubMed PMID: 23442417.

3: Franco Brunello, Brunocilla PR, Rizzetto M et alii. Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions.Med Oncol. 2013 Mar;30(1):345. doi: 10.1007/s12032-012-0345-2. Epub 2012 Dec 22. PubMed PMID: 23263829.

4: Franco Brunello, Francica G, Pompili M et aliiLong-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig Liver Dis. 2013 Apr;45(4):336-41. doi: 10.1016/j.dld.2012.10.022. Epub 2012 Dec 13. PubMed PMID: 23245589.

5: Franco Brunello, Gruden G,  Rizzetto M et alii. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma.Cell Stress Chaperones. 2013 Mar;18(2):235-41. doi: 10.1007/s12192-012-0377-8. Epub 2012 Oct 17. PubMed PMID: 23073653; PubMed Central PMCID: PMC3581631.

6: Franco Brunello, Stroffolini T et alii. Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. Dig Liver Dis. 2011 Nov;43(11):875-80. doi: 10.1016/j.dld.2011.05.002. PubMed PMID: 21684821.

7: Franco Brunello, Rizzetto M et alii. Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension. Eur J Gastroenterol Hepatol. 2011 Jul;23(7):573-7. doi: 10.1097/MEG.0b013e32834701f5. PubMed PMID: 21546840.

8: Franco Brunello, Rizzetto M et alii. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21. PubMed PMID:20932598. 

9: Brunello F, Rizzetto M et alii. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol. 2008;43(6):727-35. doi: 10.1080/00365520701885481. PubMed PMID: 18569991. 

10: Franco Brunello, Rizzetto M et alii. Assessment of liver fibrosis in the clinical setting: something is changing? Minerva Gastroenterol Dietol. 2007 Mar;53(1):111-4. Review. PubMed PMID: 17415348.

11: Franco Brunello, Rizzetto M et alii. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure  and liver fibrosis markers. J Hepatol. 2007 Jun;46(6):1026-33. Epub 2007 Feb 9. PubMed PMID: 17336417.

12: Franco Brunello, Andriulli A, et alii. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection. Aliment Pharmacol Ther. 2006 May 1;23(9):1329-35.PubMed PMID: 16629938.

06/02/2014

1. Eugenio Caturelli et alii. Which Clinical and Sonographic Parameters May Be Useful to Discriminate NASH from Steatosis? J Clin Gastroenterol. 2011 Jan;45(1):59-63. doi: 10.1097/MCG.0b013e3181dc25e3. Abstract

2. Giannini EG Caturelli E et alii.  Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study  Liver Int. 2011 Feb;31(2):192-6. doi: 10.1111/j.1478-3231.2010.02409.x. Epub 2010 Dec 10. Abstract

3. Eugenio Caturelli et alii.  Nodular regenerative hyperplasia of the liver: “coral atoll-like lesions” at ultrasound are characteristic in predisposed patients Br J Radiol. 2011 Jul;84(1003):e129-34. doi: 10.1259/bjr/17975057 Scarica il file

4. Santi V, Caturelli E et alii The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J Hepatol. 2012 Feb;56(2):397-405. doi: 10.1016/j.jhep.2011.05.026. Epub 2011 Jul 12. Abstract

5. Giannini EG Caturelli E et alii. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.  Liver Int. 2013 Nov;33(10):1594-600. doi: 10.1111/liv.12199. Epub 2013 May 8. Abstract

20/01/2014

1. Antonio Giorgio et al. Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus? AJR 2009; 193:948–954 Scarica il file

2. Antonio Giorgio et al. Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma: Retrospective Analysis of a Single Centre Experience ANTICANCER RESEARCH 31: 4575-4580 (2011)
Scarica il file

3. Antonio Giorgio et al. Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma Compared to Percutaneous Ethanol Injection in Treatment of Cirrhotic Patients: An Italian Randomized Controlled Trial ANTICANCER RESEARCH 31: 2291-2296 (2011) Scarica il file

4. Antonio Giorgio et al. Percutaneous Treatment of Hydatid Liver Cysts: An Update  Recent Patents on Anti-Infective Drug Discovery, 2012, 7, 231-236 Scarica il file